FGF19 and type 2 diabetes mellitus: Our findings suggest that total cBAs and FGF-19 have potential as biomarkers of insulin sensitivity that should be considered for future studies investigating the mechanism underlying glucose metabolism alterations predicting Type 2 diabetes risk and its sequelae.